Lexaria Bioscience Corp. - Warrant (NQ:LEXXW)
All News about Lexaria Bioscience Corp. - Warrant
Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
October 09, 2024
Lexaria Welcomes Industry Veteran as New CEO
September 05, 2024
First Results from Lexaria's Second GLP-1 Human Pilot Study
August 27, 2024
Lexaria Updates Current GLP-1 Market
October 08, 2024
Lexaria Appoints Michael Shankman as Chief Financial Officer
October 01, 2024
Lexaria Releases Strategic Letter from the Outgoing CEO
September 05, 2024
Lexaria Enters a Material Transfer Agreement for DehydraTECH Research
September 03, 2024
Positive Results from Lexaria's Molecular Characterization Study
August 19, 2024
Lexaria Preparing For Strategic Growth
July 16, 2024
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.